PlainHospital

DAVOL INC., SUB. C.R. BARD, INC. -1213643

Manufacturer adverse-event records for DAVOL INC., SUB. C.R. BARD, INC. -1213643 come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2010–2026 · mid-book · typical Death-code · injury-heavy

Injury-mix signature

DAVOL INC., SUB. C.R. BARD, INC. -1213643 leans injury-heavy in event_type mix

Injury-coded event_type share is 84.9% (injury-heavy tercile) beside 0.39% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for DAVOL INC., SUB. C.R. BARD, INC. -1213643

The standout signal for DAVOL INC., SUB. C.R. BARD, INC. -1213643 is Injury-mix: 84.9% Injury-coded (injury-heavy) beside 0.39% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for DAVOL INC., SUB. C.R. BARD, INC. -1213643. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 15 device types, led in this extract by Injury at 9,863 (84.9% of event_type total). Peak single-year volume reaches 2,317 reports across 15 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

11,618
Total Reports
45
Event-type Death
9,863
Injury Reports
15
Device Types

Event Types

Injury 9,863 (84.9%)
Malfunction 1,710 (14.7%)
Death 45 (0.4%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 5,767 (36.1%)
Disability 3,697 (23.2%)
R 3,213 (20.1%)
Other 1,948 (12.2%)
S 943 (5.9%)
L 119 (0.7%)
Hospitalization 82 (0.5%)
Life Threatening 60 (0.4%)
H 48 (0.3%)
O 41 (0.3%)
D 29 (0.2%)
Death 17 (0.1%)
1 (0.0%)
C 1 (0.0%)

Devices (15)

Device Reports
Mesh, Surgical, Polymeric 9,876
Staple, Implantable 817
Laparoscope, General & Plastic Surgery 281
Surgical Film 221
Mesh, Surgical, Absorbable, Abdominal Hernia 199
Agent, Absorbable Hemostatic, Non-Collagen Based 86
Mesh, Surgical 61
Agent, Absorbable Hemostatic, Collagen Based 22
Lavage, Jet 22
Collagen Surgical Mesh Containing Drugs 18
Laparoscope, Gynecologic (And Accessories) 7
Electrosurgical, Cutting & Coagulation & Accessories 3
Apparatus, Suction, Single Patient Use, Portable, Nonpowered 2
Sealant, Polymerizing 2
Hemostatic Wound Dressing Without Thrombin Or Other Biologics 1

Yearly Trend

10
2010: 1
13
2013: 5
14
2014: 7
15
2015: 7
16
2016: 5
17
2017: 7
18
2018: 507
19
2019: 2,317
20
2020: 2,191
21
2021: 1,647
22
2022: 1,271
23
2023: 785
24
2024: 614
25
2025: 1,307
26
2026: 947

Read our methodology - how this data is sourced, computed, and verified.